Post-Approval Commitments (PACs) are studies or analyses required by regulators after product approval to address remaining safety or efficacy questions.
PACs may include additional clinical trials, registries, or pharmacovigilance activities with defined timelines. Sponsors must track PAC obligations and submit periodic updates. Completion of PACs influences labeling decisions and long-term benefitñrisk evaluation. Strong PAC governance supports lifecycle compliance and regulatory trust.